Literature DB >> 10340793

Extensive chorioretinal atrophy in Vogt-Koyanagi-Harada disease.

S Sonoda1, K Nakao, N Ohba.   

Abstract

PURPOSE: To report extensive chorioretinal atrophy during the long-term course of Vogt-Koyanagi-Harada (VKH) disease not treated properly in the initial phase. CASES: Four patients with VKH disease were examined more than 10 years after onset of the disease. OBSERVATIONS: They presented initially with classic features of VKH disease, except 1 patient who had developed bilateral, acute angle-closure glaucoma as the initial sign. Two patients received systemic corticosteroid therapy at the acute phase of the disease. During the follow-up of 13-34 years subsequent to onset, these patients had chronic recurrent anterior uveitis with apparently stable depigmented fundus. Eventually, they developed diffuse, extensive chorioretinal atrophy that resulted in severe visual loss. One patient had an unusual familial occurrence of the disease.
CONCLUSIONS: Failure to prescribe proper corticosteroid therapy in the initial phase of VKH disease may lead to chronic recurrent uveitis. Long-standing uveitic reactions may eventually result in severe visual loss due to extensive chorioretinal degeneration.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10340793     DOI: 10.1016/s0021-5155(98)00066-5

Source DB:  PubMed          Journal:  Jpn J Ophthalmol        ISSN: 0021-5155            Impact factor:   2.447


  10 in total

1.  Ultrasound biomicroscopic study of ciliary body changes in the post-treatment phase of Vogt-Koyanagi-Harada disease.

Authors:  S Wada; T Kohno; N Yanagihara; M Hirabayashi; H Tabuchi; K Shiraki; T Miki
Journal:  Br J Ophthalmol       Date:  2002-12       Impact factor: 4.638

2.  Visual function in Vogt-Koyanagi-Harada patients.

Authors:  Soon-Phaik Chee; Chi D Luu; Ching-Li Cheng; Wee-Kiak Lim; Aliza Jap
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2005-03-11       Impact factor: 3.117

3.  The spectrum of Vogt-Koyanagi-Harada disease in Turkey: VKH in Turkey.

Authors:  Ilknur Tugal-Tutkun; Yilmaz Ozyazgan; Yonca A Akova; Yuksel Sullu; Nurettin Akyol; Merih Soylu; Haluk Kazokoglu
Journal:  Int Ophthalmol       Date:  2006-09-07       Impact factor: 2.031

4.  Retinal pigment epithelial changes in chronic Vogt-Koyanagi-Harada disease: fundus autofluorescence and spectral domain-optical coherence tomography findings.

Authors:  Daniel V Vasconcelos-Santos; Elliott H Sohn; Srinivas Sadda; Narsing A Rao
Journal:  Retina       Date:  2010-01       Impact factor: 4.256

5.  Vogt-Koyanagi-Harada syndrome associated with cutaneous malignant melanoma: an 11-year follow-up.

Authors:  Sabine Aisenbrey; Christoph Lüke; Helen D Ayertey; Salvatore Grisanti; Andreas Perniok; Richard Brunner
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2003-11-14       Impact factor: 3.117

6.  Suboptimal therapy controls clinically apparent disease but not subclinical progression of Vogt-Koyanagi-Harada disease.

Authors:  Tatsushi Kawaguchi; Shintaro Horie; Nadia Bouchenaki; Kyoko Ohno-Matsui; Manabu Mochizuki; Carl P Herbort
Journal:  Int Ophthalmol       Date:  2009-01-17       Impact factor: 2.031

7.  Relative changes in luminal and stromal areas of choroid determined by binarization of EDI-OCT images in eyes with Vogt-Koyanagi-Harada disease after treatment.

Authors:  Hiroki Kawano; Shozo Sonoda; Takehiro Yamashita; Ichiro Maruko; Tomohiro Iida; Taiji Sakamoto
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2016-02-04       Impact factor: 3.117

8.  Prognostic factors in Vogt-Koyanagi-Harada disease.

Authors:  Abdullah S Al-Kharashi; Hassan Aldibhi; Hamad Al-Fraykh; Dustan Kangave; Ahmed M Abu El-Asrar
Journal:  Int Ophthalmol       Date:  2007-04-14       Impact factor: 2.029

9.  Indocyanine green angiography guided management of vogt-koyanagi-harada disease.

Authors:  Nadia Bouchenaki; Carl P Herbort
Journal:  J Ophthalmic Vis Res       Date:  2011-10

Review 10.  Vogt-Koyanagi-Harada disease: review of a rare autoimmune disease targeting antigens of melanocytes.

Authors:  Marcelo Mendes Lavezzo; Viviane Mayumi Sakata; Celso Morita; Ever Ernesto Caso Rodriguez; Smairah Frutuoso Abdallah; Felipe T G da Silva; Carlos Eduardo Hirata; Joyce Hisae Yamamoto
Journal:  Orphanet J Rare Dis       Date:  2016-03-24       Impact factor: 4.123

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.